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Objective— Recent studies suggested the occurrence of phenotypic switching of 2	
vascular smooth muscle cells (VSMCs) during the development of aortic aneurysm 3	
(AA). However, lineage-tracing studies are still lacking and the behavior of VSMCs 4	
during the formation of dissecting AA is poorly understood. 5	
Approach and Results— We used multicolor lineage tracing of VSMCs to track their 6	
fate after injury in murine models of angiotensin II-induced dissecting AA. We also 7	
addressed the direct impact autophagy on the response of VSMCs to AA dissection. 8	
Finally, we studied the relevance of these processes to human AAs. Here, we show 9	
that a subset of medial VSMCs undergoes clonal expansion and that VSMC 10	
outgrowths are observed in the adventitia and the borders of the false channel during 11	
angiotensin II-induced development of dissecting AA. The clonally expanded VSMCs 12	
undergo phenotypic switching with downregulation of VSMC differentiation markers 13	
and upregulation of phagocytic markers, indicative of functional changes. In 14	
particular, autophagy and endoplasmic reticulum (ER) stress responses are activated 15	
in the injured VSMCs. Loss of autophagy in VSMCs through deletion of autophagy 16	
protein 5 gene (Atg5) increases the susceptibility of VSMCs to death, enhances ER 17	
stress activation, and promotes inositol-requiring enzyme (IRE)1α-dependent VSMC 18	
inflammation. These alterations culminate in increased severity of aortic disease and 19	
higher incidence of fatal AA dissection in mice with VSMC-restricted deletion of Atg5. 20	
We also report increased expression of autophagy and ER stress markers in VSMCs 21	
of human dissecting AAs.  22	
Conclusions— VSMCs undergo clonal expansion and phenotypic switching in 23	
angiotensin II-induced dissecting aortic aneurysms in mice. We also identify a critical 24	
	 4	
role for autophagy in regulating VSMC death and ER stress-dependent inflammation 1	
with important consequences for aortic wall homeostasis and repair. 2	
 3	
Abbreviations: 4	
AA: aortic aneurysm 5	
Ang: angiotensin 6	
Apoe: apolipoprotein e 7	
ATG5: autophagy protein 5 8	
ATG16L1: autophagy protein 16 like 1 9	
ER: endoplasmic reticulum 10	
IRE: inositol-requiring enzyme 11	
LAMP2: Lysosomal Associated Membrane Protein 2 12	
LC3: microtubule-associated protein 1 light chain 3  13	
SMA: smooth muscle actin 14	
TGF: transforming growth factor 15	





The response of vascular smooth muscle cells (VSMCs) to injury is a major 2	
determinant of the development and progression of vascular diseases, including 3	
atherosclerosis, restenosis, and aneurysm 1-3. In response to injury and inflammation, 4	
VSMCs undergo phenotypic switching from a quiescent contractile phenotype to a 5	
proliferative, migratory, and synthetic phenotype, and can acquire molecular and 6	
cellular features of mesenchymal stem cells and macrophages 4. VSMC plasticity is 7	
well-documented during atherosclerosis and neointima formation, and has been 8	
confirmed using lineage-tracing experiments 5-8. More recently, using multicolor 9	
lineage labeling, we demonstrated that VSMC accumulation in atherosclerotic 10	
plaques and injury-induced neointimal lesions results from extensive proliferation of a 11	
small subset of differentiated but highly plastic medial VSMCs, a variable proportion 12	
of which undergo phenotypic switching to phagocyte-like cells 9. VSMCs also play 13	
important roles in the pathophysiology of aortic aneurysm (AA), and recent studies 14	
suggested a role for some aspects of VSMC phenotypic switching in AA 10, 11. 15	
However, the plasticity of VSMCs during AA formation has not been assessed. 16	
Here we used multicolor lineage labeling of VSMCs to characterize the behavior of 17	
VSMCs during the development and progression of angiotensin II (AngII)-induced 18	
dissecting AA. We report the occurrence of clonal expansion of a subset of VSMCs in 19	
the media, which can outgrow into the adventitia (including the false-channel’s 20	
borders) of the dissecting AA. The expanded VSMCs undergo phenotypic switching 21	
to phagocyte-like cells, and can upregulate autophagy and endoplasmic reticulum 22	
(ER) stress markers. Importantly, loss of autophagy in VSMCs promotes VSMC 23	
death and ER stress-dependent VSMC inflammation, and aggravates the aortic 24	
disease.   25	
	 6	
METHODS 1	
Data disclosure statement 2	
The data that support the findings of this study are available from the corresponding 3	
authors.  4	
Animals 5	
All experiments were performed according to Home Office, UK regulations and 6	
approved by the local ethics committee. For lineage tracing, Myh11-7	
CreERt2/ROSA26-Confetti males were subjected to 10 intraperitoneal injections of 1 8	
mg tamoxifen over 2 weeks followed by at least 1 week washout. TaglnCre+/Atg5flox/flox 9	
animals were used to assess the role of autophagy in VSMC. Infusion of 1µg/min/Kg 10	
AngII, with or without treatment with 10mg/Kg anti-transforming growth factor (TGF)β 11	
(clone 1.D.11, BioXCell) was used to induce dissecting AA. Animals were analyzed 12	
as described in the Online Data Supplement. 13	
Statistical analysis 14	
Values are shown as average ± SEM. Differences between groups were evaluated 15	
using Mann-Whitney test (2 groups), Kruskal-Wallis test followed by uncorrected 16	
Dunn’s test (> 2 groups), 2-way ANOVA (cell proliferation/survival) or Chi2 test 17	
(distribution between 2 groups), as indicated in figure legends. Results were 18	
considered statistically significant at P<0.05. 19	
 20	
RESULTS 21	
Characterization of VSMCs during aortic dissection induced by AngII  22	
VSMCs downregulate contractile gene expression during AA formation 10, 11. 23	
However, the plasticity of VSMCs during AA formation has not been fully 24	
characterized. To this end, we used a prototypical model of dissecting AA induced by 25	
	 7	
AngII, with or without TGFβ inhibition 12, 13. We first stained for αSMA on cross-1	
sections of mice with aortic dissections. We observed accumulation of αSMA+ cells in 2	
the false channel in 5 out of 5 animals displaying aortic dissection in this experiment. 3	
These αSMA+ cells seemed to expand from the media (Figure 1A), and accumulated 4	
in hemorrhagic/thrombotic areas in contact with iron (Perl’s staining, Figure 1B), and 5	
red blood cells, which may explain their acquisition of heme oxygenase (HMOX)1 6	
expression (Figure 1C). αSMA+ cells detected in the thrombotic/hemorrhagic region 7	
also showed increased expression of the phagocytic marker CD68 (Figure 1D) and 8	
the lysosomal marker LAMP2 (Figure 1E), suggesting that some VSMCs switched 9	
towards phagocyte-like cells. We further confirmed our results using flow cytometry 10	
analysis of aortic cells isolated from Apoe-/- mice infused with AngII for 21 days 11	
(Figure 2). The proportion of VSMCs (αSMAhighCD90-) with high expression of αSMA 12	
markedly decreased in dissected aortas compared to controls, whereas a substantial 13	
proportion of αSMAintCD90high (myofibroblasts) and αSMAlowCD90high (fibroblasts) 14	
(Figure 2A) were observed in diseased aortas. VSMCs, myofibroblasts and 15	
fibroblasts acquired phagocytic markers LAMP2 (Figure 2B) and CD68 (Figure 2C-16	
D) proportionally to the severity of aortic disease, and cells from dissecting 17	
aneurysms were positive for Ter-119, suggesting an association with red blood cells 18	
(Figure 2F-G). These results suggest that a substantial proportion of VSMCs, 19	
myofibroblasts and fibroblasts adopt a phagocyte-like phenotype in dissecting AA.  20	
 21	
VSMC clonal expansion and phenotypic switching in dissecting AA 22	
In order to test whether the αSMA+ cells that have accumulated in the adventitia have 23	
originated from pre-existing VSMCs, we used multicolor lineage tracing in Myh11-24	
CreERt2/Rosa26-Confetti mice to track VSMCs and their progeny 9. VSMCs were 25	
	 8	
labeled by tamoxifen injections before the induction of AA by AngII infusion and 1	
TGFβ inhibition (Figure 3). Stochastic labeling of VSMCs using this method results in 2	
a mosaic pattern in the non-injured aortic media 9. We found that αSMA+ cells that 3	
accumulated in the adventitia and the false channel in mice with aortic dissection 4	
were also positive for Confetti fluorescent reporters (5 out of 6 mice) indicating that 5	
they were VSMC derived-cells coming from the media (Figure 3A). Interestingly, in 6	
contrast to the stochastic mosaic labeling of the normal aortic media, VSMC-derived 7	
cells in the adventitia displayed a non-random color distribution (Figure 3A). We 8	
observed large regions containing lineage-labelled cells of a single color or 9	
intermixed single colors in all (5/5) animals with VSMC-derived Confetti+ cells outside 10	
the medial layer, suggesting that these cell outgrowths are derived from clonal 11	
expansion of a small number of cells (Figure 3A). We also found monochromatic 12	
patches of VSMCs in the medial layer of 5 out of the 6 animals analyzed (>5 cells per 13	
patch, Figure 3B and Figure I in the online-only Data Supplement), suggesting 14	
that proliferation is activated in a subset of medial VSMCs. The clonally expanded 15	
VSMCs observed in the adventitial outgrowths and in medial monochromatic patches 16	
significantly downregulated their αSMA expression (Figure 3A and 3B and Figure II 17	
in the online-only Data Supplement), further supporting that these cells undergo 18	
phenotypic switching. To examine whether the accumulation of VSMC-derived cells 19	
in the dissected area was a result of TGFβ inhibition, we lineage-traced VSMCs in 20	
apolipoprotein e (Apoe)-/- animals that develop dissecting AA after AngII treatment in 21	
the absence of TGFβ inhibition. The occurrence and extent of monochromatic 22	
patches was not affected by TGFβ neutralization in AngII-treated animals (8/15 Apoe-23	
/- without anti-TGFβ and 6/10 Apoe-/- with anti-TGFβ) (Figure 3C). Confetti-positive 24	
cells were observed in the thrombotic/hemorrhagic area of 3/6 Apoe-/- animals 25	
	 9	
displaying limited aortic dissection (Figure III in the online-only Data Supplement). 1	
Analysis of EdU incorporation (Figure 3D) confirmed that VSMCs were proliferating 2	
both in the media (Figure 3E) and in the adventitial outgrowth areas of dissected 3	
aortas (Figure 3F and Figure IV in the online-only Data Supplement). Confetti+ 4	
cells in the media expressed almost no phagocytic markers, but the Confetti+ cells 5	
that have expanded into the adventitia, started to express HMOX1, CD68 and 6	
LAMP2 (Figure 3G). CD90 expression was undetectable in Confetti+ cells, except for 7	
a few cells with very low expression (data not shown). Our data indicate that clonal 8	
proliferation and phenotypic switching of medial VSMCs are important features of 9	
AngII-induced aortic dissection. 10	
 11	
Atg5 deficiency in VSMCs promotes the development of severe aortic 12	
dissection  13	
The lysosomal pathway, and particularly LAMP2, controls autophagosome 14	
maturation 14. Moreover, autophagy plays critical roles in VSMC biology 15 and has 15	
recently been linked with VSMC phenotypic switching 16. Defective autophagy in 16	
VSMC is associated with accelerated VSMC senescence, neointima formation and 17	
atherogenesis 15, 17, but its role in the pathophysiology of dissecting AA is still 18	
uncertain 18. Studying aortic cross sections, we found increased expression of 19	
autophagy-related protein 16 like 1 (ATG16L1) in medial and adventitial αSMA+ cells 20	
of dissecting AA (5 out of 5) compared to very limited staining in VSMCs of healthy 21	
aortas (Figure 4A), suggesting a potential role of autophagy in this disease 22	
condition. We confirmed that ATG16L1 is expressed in VSMC-derived cells, using 23	
the Confetti lineage tracing animals (Figure VA in the online-only Data 24	
Supplement). ATG5 is essential for all types of autophagy, and we found that ATG5 25	
	 10	
was also expressed in VSMC-derived Confetti+ cells (Figure VB and VC in the 1	
online-only Data Supplement). Furthermore, Atg5 gene expression was 2	
upregulated in primary VSMCs at passage 4 in culture compared to ex vivo primary 3	
VSMCs (Figure VD in the online-only Data Supplement), further supporting a 4	
potential role of autophagy in phenotypically switched VSMCs. Using 5	
TaglnCre+/Atg5flox/flox mice (Figure VIA in the online-only Data Supplement), we 6	
investigated the impact of defective autophagy in VSMCs on the incidence of aortic 7	
dissection in mice. There was no difference in the blood pressure response to AngII 8	
between TaglnCre+/Atg5flox/flox and TaglnCre-/Atg5flox/flox mice (Figure VIB in the online-9	
only Data Supplement). Over 28 days, mice with Atg5 deficiency in VSMCs showed 10	
reduced survival compared with their WT littermates (Figure 4B). 9 out of 17 11	
TaglnCre+/Atg5flox/flox mice died from aortic rupture compared to 2 out of 14 TaglnCre-12	
/Atg5flox/flox mice (Figure 4C and 4D). Moreover, 3 out of 17 TaglnCre+/Atg5flox/flox mice 13	
died without evidence of aortic rupture at autopsy, but instead presented with 14	
hemorrhage in the peritoneum, spleen and intestine, suggesting vascular impairment 15	
in those organs. Analysis of aortic tissue samples showed that vascular injury 16	
induced by AngII + anti-TGFβ was significantly more severe in mice with VSMC-17	
restricted Atg5 deletion (Figure 4D), with higher levels of iron deposition (blue Perl’s 18	
staining) in the media and adventitia (Figure 4E-F) as compared to their littermate 19	
controls. Thus, defective autophagy in VSMCs increases the incidence and severity 20	
of aortic dissection. 21	
 22	
Atg5 deficiency in VSMCs impedes autophagosome formation and enhances 23	
cell death 24	
	 11	
To confirm that Atg5 deficiency inhibits autophagy in VSMCs, we analyzed the 1	
expression of microtubule-associated protein 1 light chain 3 (LC3) in αSMA+ cells 2	
after the induction of AA. Punctate LC3 staining, associated with autophagosome 3	
formation, was significantly reduced in TaglnCre+/Atg5flox/flox mice compared to 4	
TaglnCre-/Atg5flox/flox control animals (Figure 5A). Conversely, Atg5 deficiency in 5	
VSMCs led to a significant accumulation of the autophagosome cargo protein 6	
Sqstm1/p62 (Figure 5B) as well as LAMP2 (Figure 5C). Loss of Atg5 was 7	
associated with an increase of apoptotic VSMCs in the media, as shown by active 8	
CASPASE-3 staining (Figure 5D) suggesting that autophagy promotes cell survival. 9	
This was confirmed using in vitro experiments, which revealed a substantial reduction 10	
of VSMC survival (Figure 5E) and proliferation (Figure 5F) in response to serum, 11	
and an increased susceptibility to ER stress-induced cell death (Figure 5G) in the 12	
absence of Atg5. 13	
 14	
Atg5 deficiency in VSMCs promotes an ER stress response and IRE1α-15	
dependent inflammation  16	
There is a close interplay between autophagy and the ER stress response, and 17	
recent studies indicate that autophagy may resolve ER stress responses through 18	
direct removal of IRE1α 19. Consistent with the latter finding, we observed a 19	
substantial accumulation of the ER stress sensor IRE1α in Atg5-deficient VSMCs in 20	
vivo (Figure 6A). In vitro cultured Atg5-deficient VSMCs also showed substantial 21	
accumulation of IRE1α in the absence of any external stimulus (Figure 6B). VSMCs 22	
respond to IL1 stimulation by abundant secretion of inflammatory cytokines 20 and 23	
chemokines 21. Interestingly, IL1β-induced expression of IL6 (Figure 6C), CXCL1 24	
and CCL2 (Figure VII in the online-only Data Supplement) was significantly higher 25	
	 12	
in Atg5-deficient VSMCs compared to WT control cells and was abrogated by 1	
inhibition of IRE1α kinase activity. Consistent with the increased inflammatory 2	
response, aortic sections of TaglnCre+/Atg5flox/flox mice treated with AngII + anti-TGFβ 3	
showed increased neutrophil accumulation compared to TaglnCre-/Atg5flox/flox control 4	
mice (Figure 6D). We also found a tendency (P=0.06) towards increased circulating 5	
levels of IL-6 in TaglnCre+/Atg5flox/flox compared to TaglnCre-/Atg5flox/flox mice; however, 6	
other tested circulating cytokines and chemokines were not different between the 2 7	
groups (Figure VII in the online-only Data Supplement). These results indicate 8	
that autophagy-dependent regulation of ER stress modulates VSMC and local aortic 9	
inflammation.  10	
 11	
Autophagy and ER stress are features of human aortic dissection  12	
To examine the relevance of our findings to human pathology, we analyzed sections 13	
of human aortas with or without dissection, collected from separate patients. We 14	
found that 4 out of 5 samples with aortic dissection contained αSMA+ and TAGLN+ 15	
cells (Figure 7A) in areas devoid of elastic lamellae outside the media, whereas such 16	
features could not be detected in non-dissected normal aortas (n=5) (Figure VIII in 17	
the online-only Data Supplement). The vast majority of adventitial αSMA+ cells did 18	
not express CD90 (Figure IX in the online-only Data Supplement) indicating that 19	
they were not of fibroblast origin, and suggesting that they have most likely expanded 20	
from the aortic media. Although LC3 expression in VSMCs was similar between non-21	
dissected and dissected aortas (Figure 7B), the latter showed increased 22	
accumulation of the autophagosome cargo protein SQSTM1/p62 (Figure 7C), and 23	
increased expression of the ER stress marker GRP78/Bip (Figure 7D). Our data 24	
	 13	
suggest that VSMCs of dissected AAs in humans may have deregulated autophagy 1	
resulting in ER stress activation. 2	
 3	
DISCUSSION 4	
Previous work on the role of VSMCs in AA has focused on the detrimental effects of 5	
VSMC death in promoting adverse arterial wall remodeling due to reported medial 6	
thinning, degeneration and extensive apoptosis of VSMCs in very late stages of AA 7	
development 22, 23. Notably however, despite medial thinning and VSMC death, 8	
ascending thoracic AAs show an increase in overall medial area and have preserved 9	
VSMC density, suggesting a hyperplastic response 24, 25. Animal models of AA also 10	
suggest that VSMCs display some aspects of phenotypic switching early during the 11	
development of both thoracic and abdominal AA 10, 11. Here, we have tested the 12	
hypothesis that a hyperplastic VSMC response could compensate for increased 13	
VSMC death during AA development. Using lineage tracing of pre-existing VSMCs in 14	
mice, we found that in response to AngII infusion, a subset of VSMCs clonally 15	
expand in the media of the thoracic and abdominal aorta, and in the context of aortic 16	
dissection, expand through the aortic wall into the adventitia and the newly formed 17	
false channel. We propose that the resulting VSMC-derived cells might play a 18	
reparative role at several disease stages, from aneurysm development to aneurysm 19	
dissection. Interestingly, large foci of VSMCs also accumulate in areas of extensive 20	
elastin degradation corresponding to the external medial layers and adjacent 21	
adventitia of human thoracic AAs, suggesting similar pathophysiological mechanisms 22	
in human AAs.  23	
Our lineage-tracing experiments demonstrate that a subset of pre-existing VSMCs 24	
proliferate, downregulate contractile protein expression and upregulate proteins 25	
	 14	
associated with a phagocytic-like phenotype in AA. This resembles the VSMC 1	
behavior observed in other vascular disease models 6-9, suggesting that the 2	
extensive plasticity is an inherent physiologically relevant feature of VSMCs. 3	
Importantly, we found many examples of clonal proliferation resulting in 4	
monochromatic patches within the medial layer in animals showing no signs of aortic 5	
dissection. This observation suggests that activation of proliferation occurs in a larger 6	
proportion of VSMCs than what was estimated from the clonal VSMC contribution to 7	
neointima formation after vascular injury 9.  8	
The finding that VSMCs downregulate the contractile phenotype in AA is consistent 9	
with and further validates previous work 10, 11, 26. Two recent studies reported that 10	
interference with molecular pathways involved in VSMC phenotypic switching may 11	
have detrimental effects in AA. VSMC-restricted deletion of KLF4, which has 12	
previously been identified as a regulator of several aspects of VSMC phenotypic 13	
switching in atherosclerosis 7, reduced aortic disease severity in mouse models of AA 14	
26, although it did not abrogate the disease. A more recent study identified a role for 15	
HDAC9-MALAT1-BRG1 complex in the downregulation of the contractile VSMC 16	
phenotype in AAs driven by mutations of the TGFβ pathway; VSMC-restricted 17	
deletion of MALAT1 significantly preserved the contractile phenotype of VSMCs and 18	
reduced AA development in a mouse mode of Marfan with Fbn1 mutation 11. These 19	
studies are consistent with a detrimental role of the downregulation of the contractile 20	
phenotype of VSMCs in AAs. However, KLF4 and MALAT1 may impact other VSMC 21	
functions beyond, and maybe independently, of their role in regulating the contractile 22	
phenotype of VSMCs.  23	
Beyond the downregulation of differentiation and contractile markers of VSMCs, 24	
VSMC phenotypic switching induces a wide range of functions, which might have 25	
	 15	
opposing functions on AA formation and progression. Here, we assessed the 1	
particular role of VSMC autophagy in AA, and found that loss of Atg5 in VSMC 2	
reduced autophagosome generation and resulted in increased disease progression 3	
and mortality in AngII-treated animals with TGFβ inhibition. Previously, the role of 4	
VSMC autophagy in the development of AA was examined in Atg7flox/flox/TaglnCre/+ 5	
mice 18. The authors concluded that mice with smooth muscle cell-specific Atg7 6	
deficiency do not develop dissecting abdominal AA in response to AngII 18. 7	
Importantly, that study was conducted using AngII infusion under normo-8	
cholesterolemic conditions where mice are resistant to AA 12, 13. Additional cues, such 9	
as the presence of hypercholesterolemia 12 or the concomitant blockade of TGFβ 10	
signaling pathway 13, 27, are required to promote the susceptibility of the aorta to 11	
aneurysm formation and dissection in response to AngII infusion. In our present 12	
study, the use of a previously validated model of dissecting AA 13, 27 revealed a clear 13	
detrimental effect of defective autophagy in VSMCs on AA development. The 14	
incidence and severity of dissected AAs were significantly higher in mice with Atg5 15	
deletion in VSMCs. Of note, 18% of the mice (25% of the mice that died suddenly) 16	
showed evidence of extra-aortic hemorrhage in the peritoneum, spleen and intestine, 17	
suggesting that defective autophagy in VSMCs may be associated with widespread 18	
impairment of the vascular response to injury. Taken together, the data show that 19	
autophagy in VSMCs is critically required for the maintenance of vascular integrity 20	
during the development and progression of AAs. This vasculo-protective effect may 21	
be explained at least in part, by the role of autophagy in preserving VSMC survival in 22	
response to injury. Our data also identify a role of autophagy in the regulation of 23	
VSMC inflammation, potentially through the degradation of IRE1α 19. IRE1α has 24	
previously been involved in mediating inflammatory responses downstream of toll-like 25	
	 16	
receptors 28, 29 and C-type lectin receptors 30 but its role in IL1R1 signaling pathways 1	
has not been addressed. We speculate that this inter-connection between 2	
autophagy, ER stress responses and inflammatory pathways is of major importance 3	
to the outcome of the reparative process after injury, and merits further consideration. 4	
Finally, the direct impact of autophagy on the regulation of VSMC clonal proliferation 5	
and phenotypic switching will need to be addressed. It will also be interesting to 6	




We provide genetic evidence for the activation of VSMC proliferation, selective clonal 11	
expansion and phenotypic switching towards phagocytic-like phenotypes in VSMCs 12	
during the development of dissecting AA. We identify a critical role for autophagy in 13	
the preservation of vessel integrity, possibly through limitation of VSMC death and 14	
ER stress-dependent inflammation. The results advance our understanding of the 15	
reparative mechanisms that operate during aneurysm development and progression, 16	
which could be exploited clinically. Future studies to identify the precise stimuli 17	
responsible for VSMC proliferation and accumulation in this context are important to 18	




The authors would like to thank the Wellcome Trust - Medical Research Council, 2	
Institute of Metabolic Science, Metabolic Research Laboratories, Imaging core, 3	
Wellcome Trust Strategic Award (100574/Z/12/Z) and the Cambridge National 4	
Institute for Health Research Biomedical Research Centre Cell Phenotyping Hub. 5	
 6	
SOURCES OF FUNDING 7	
Z.M. is supported by the British Heart Foundation, UK. The project also received 8	
funding from INSERM, France. J.C. and A.T. are supported by British Heart 9	
Foundation (BHF) studentships (RE/13/6/30180, FS/14/59/31282). H.F.J. is 10	
supported by the BHF Cambridge Centre for Research Excellence (RE/13/6/30180) 11	








1. Alexander MR, Owens GK. Epigenetic control of smooth muscle cell 2	
differentiation and phenotypic switching in vascular development and disease. Annu 3	
Rev Physiol. 2012;74:13-40. 4	
2. Tellides G, Pober JS. Inflammatory and immune responses in the arterial 5	
media. Circ Res. 2015;116:312-322. 6	
3. Bennett MR, Sinha S, Owens GK. Vascular Smooth Muscle Cells in 7	
Atherosclerosis. Circ Res. 2016;118:692-702. 8	
4. Gomez D, Swiatlowska P, Owens GK. Epigenetic Control of Smooth Muscle 9	
Cell Identity and Lineage Memory. Arterioscler Thromb Vasc Biol. 2015;35:2508-10	
2516. 11	
5. Herring BP, Hoggatt AM, Burlak C, Offermanns S. Previously differentiated 12	
medial vascular smooth muscle cells contribute to neointima formation following 13	
vascular injury. Vasc Cell. 2014;6:21. 14	
6. Feil S, Fehrenbacher B, Lukowski R, Essmann F, Schulze-Osthoff K, Schaller 15	
M, Feil R. Transdifferentiation of vascular smooth muscle cells to macrophage-like 16	
cells during atherogenesis. Circ Res. 2014;115:662-667. 17	
7. Shankman LS, Gomez D, Cherepanova OA, Salmon M, Alencar GF, Haskins 18	
RM, Swiatlowska P, Newman AA, Greene ES, Straub AC, Isakson B, Randolph GJ, 19	
Owens GK. KLF4-dependent phenotypic modulation of smooth muscle cells has a 20	
key role in atherosclerotic plaque pathogenesis. Nat Med. 2015;21:628-637. 21	
8. Cherepanova OA, Gomez D, Shankman LS, et al. Activation of the 22	
pluripotency factor OCT4 in smooth muscle cells is atheroprotective. Nat Med. 23	
2016;22:657-665. 24	
	 19	
9. Chappell J, Harman JL, Narasimhan VM, Yu H, Foote K, Simons BD, Bennett 1	
MR, Jorgensen HF. Extensive Proliferation of a Subset of Differentiated, yet Plastic, 2	
Medial Vascular Smooth Muscle Cells Contributes to Neointimal Formation in Mouse 3	
Injury and Atherosclerosis Models. Circ Res. 2016;119:1313-1323. 4	
10. Ailawadi G, Moehle CW, Pei H, Walton SP, Yang Z, Kron IL, Lau CL, Owens 5	
GK. Smooth muscle phenotypic modulation is an early event in aortic aneurysms. J 6	
Thorac Cardiovasc Surg. 2009;138:1392-1399. 7	
11. Lino Cardenas CL, Kessinger CW, Cheng Y, et al. An HDAC9-MALAT1-BRG1 8	
complex mediates smooth muscle dysfunction in thoracic aortic aneurysm. Nat 9	
Commun. 2018;9:1009. 10	
12. Daugherty A, Manning MW, Cassis LA. Angiotensin II promotes 11	
atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin 12	
Invest. 2000;105:1605-1612. 13	
13. Wang Y, Ait-Oufella H, Herbin O, Bonnin P, Ramkhelawon B, Taleb S, Huang 14	
J, Offenstadt G, Combadiere C, Renia L, Johnson JL, Tharaux PL, Tedgui A, Mallat 15	
Z. TGF-beta activity protects against inflammatory aortic aneurysm progression and 16	
complications in angiotensin II-infused mice. J Clin Invest. 2010;120:422-432. 17	
14. Saftig P, Beertsen W, Eskelinen EL. LAMP-2: a control step for phagosome 18	
and autophagosome maturation. Autophagy. 2008;4:510-512. 19	
15. De Meyer GR, Grootaert MO, Michiels CF, Kurdi A, Schrijvers DM, Martinet 20	
W. Autophagy in vascular disease. Circ Res. 2015;116:468-479. 21	
16. Song TF, Huang LW, Yuan Y, Wang HQ, He HP, Ma WJ, Huo LH, Zhou H, 22	
Wang N, Zhang TC. LncRNA MALAT1 regulates smooth muscle cell phenotype 23	
switch via activation of autophagy. Oncotarget. 2018;9:4411-4426. 24	
	 20	
17. Grootaert MO, da Costa Martins PA, Bitsch N, Pintelon I, De Meyer GR, 1	
Martinet W, Schrijvers DM. Defective autophagy in vascular smooth muscle cells 2	
accelerates senescence and promotes neointima formation and atherogenesis. 3	
Autophagy. 2015;11:2014-2032. 4	
18. Ramadan A, Singh KK, Quan A, Plant PJ, Al-Omran M, Teoh H, Verma S. 5	
Loss of vascular smooth muscle cell autophagy exacerbates angiotensin II-6	
associated aortic remodeling. J Vasc Surg. 2017. 7	
19. Tschurtschenthaler M, Adolph TE, Ashcroft JW, et al. Defective ATG16L1-8	
mediated removal of IRE1alpha drives Crohn's disease-like ileitis. J Exp Med. 9	
2017;214:401-422. 10	
20. Loppnow H, Libby P. Proliferating or interleukin 1-activated human vascular 11	
smooth muscle cells secrete copious interleukin 6. J Clin Invest. 1990;85:731-738. 12	
21. Alexander MR, Murgai M, Moehle CW, Owens GK. Interleukin-1beta 13	
modulates smooth muscle cell phenotype to a distinct inflammatory state relative to 14	
PDGF-DD via NF-kappaB-dependent mechanisms. Physiol Genomics. 2012;44:417-15	
429. 16	
22. Lopez-Candales A, Holmes DR, Liao S, Scott MJ, Wickline SA, Thompson 17	
RW. Decreased vascular smooth muscle cell density in medial degeneration of 18	
human abdominal aortic aneurysms. Am J Pathol. 1997;150:993-1007. 19	
23. Henderson EL, Geng YJ, Sukhova GK, Whittemore AD, Knox J, Libby P. 20	
Death of smooth muscle cells and expression of mediators of apoptosis by T 21	
lymphocytes in human abdominal aortic aneurysms. Circulation. 1999;99:96-104. 22	
24. Lesauskaite V, Tanganelli P, Sassi C, Neri E, Diciolla F, Ivanoviene L, 23	
Epistolato MC, Lalinga AV, Alessandrini C, Spina D. Smooth muscle cells of the 24	
media in the dilatative pathology of ascending thoracic aorta: morphology, 25	
	 21	
immunoreactivity for osteopontin, matrix metalloproteinases, and their inhibitors. Hum 1	
Pathol. 2001;32:1003-1011. 2	
25. Tang PC, Coady MA, Lovoulos C, Dardik A, Aslan M, Elefteriades JA, Tellides 3	
G. Hyperplastic cellular remodeling of the media in ascending thoracic aortic 4	
aneurysms. Circulation. 2005;112:1098-1105. 5	
26. Salmon M, Johnston WF, Woo A, Pope NH, Su G, Upchurch GR, Jr., Owens 6	
GK, Ailawadi G. KLF4 regulates abdominal aortic aneurysm morphology and deletion 7	
attenuates aneurysm formation. Circulation. 2013;128:S163-174. 8	
27. Chen X, Rateri DL, Howatt DA, Balakrishnan A, Moorleghen JJ, Cassis LA, 9	
Daugherty A. TGF-beta Neutralization Enhances AngII-Induced Aortic Rupture and 10	
Aneurysm in Both Thoracic and Abdominal Regions. PLoS One. 2016;11:e0153811. 11	
28. Qiu Q, Zheng Z, Chang L, et al. Toll-like receptor-mediated IRE1alpha 12	
activation as a therapeutic target for inflammatory arthritis. EMBO J. 2013;32:2477-13	
2490. 14	
29. Bettigole SE, Glimcher LH. Endoplasmic reticulum stress in immunity. Annu 15	
Rev Immunol. 2015;33:107-138. 16	
30. Clement M, Basatemur G, Masters L, Baker L, Bruneval P, Iwawaki T, 17	
Kneilling M, Yamasaki S, Goodall J, Mallat Z. Necrotic Cell Sensor Clec4e Promotes 18	
a Proatherogenic Macrophage Phenotype Through Activation of the Unfolded Protein 19	






• Vascular smooth muscle cells (VSMCs) of the aortic media undergo clonal 3	
expansion in mouse models of dissecting aortic aneurysms. 4	
• The clonally expanded VSMCs undergo phenotypic switching towards 5	
phagocytic-like phenotypes. 6	
• Autophagy and endoplasmic reticulum (ER) stress responses are activated in 7	
some VSMCs. Autophagy in VSMCs control inositol-requiring enzyme 8	
(IRE)1α-dependent VSMC inflammation.  9	
• We identify a critical role for autophagy in preserving vessel integrity and 10	
reducing the occurrence and severity of aortic dissection, possibly through 11	
limitation of VSMC death and ER stress-dependent inflammation.  12	
• Our results suggest that promotion of proliferation and autophagy in VSMCs 13	
while inhibiting IRE1α-dependent inflammation may promote aortic wall repair 14	




Figure 1. αSMA+ cells accumulate outside of the media and express phagocytic 2	
makers after aortic dissection. 3	
A-C – Representative images of anti-αSMA staining on cross sections of abdominal 4	
aortas from mice treated with AngII and anti-TGFβ for 10 days showing αSMA+ cell 5	
outgrowths from the medial layer (A, right panel), as compared to sections from 6	
control mice (A, left panel). On consecutive sections, Perl’s (B) and anti-HMOX1 (C) 7	
staining show that αSMA+ cells in an iron rich environment (Perl’s+) express the 8	
heme catabolic enzyme (HMOX1). D-F – Representative images of cryosections co-9	
stained for αSMA and CD68 (D) or LAMP2 (E) showing that CD68 and LAMP2 10	
colocalize with αSMA+ cells in the adventitial layers of aortic dissection. Hoechst 11	
(blue) represents nuclear staining. Images are representative of immunostainings 12	
done on 5 mice with aortic dissection. 13	
 14	
Figure 2. Vascular smooth muscle cells, fibroblasts and myofibroblasts 15	
express phagocytic markers after aortic dissection (AD). 16	
Flow cytometric analysis of stromal cells (CD45-) in the aorta of 5-month-old male 17	
Apoe-/- mice infused with AngII for 21 days (n=13). Littermate control Apoe-/- mice 18	
were left untreated (top panel, n=4).  A – Left panel: Representative images of aortic 19	
samples from untreated or AngII infused Apoe-/- mice that either did not (no AD) or 20	
did develop an aortic dissection (AD). Enzymatically digested aortas were analysed 21	
by flow cytometry. Middle/right panel: Representative dot plots showing the gating 22	
strategy used to analyze αSMAhighCD90- cells (VSMCs), αSMA-CD90+ (fibroblast 23	
phenotype) and αSMAlowCD90+ (myofibroblasts). Aortic dissection induced by AngII 24	
(lower panel, n=4 mice) dramatically reduced the percentage of αSMAhighCD90- cells 25	
	 24	
(VSMCs) within CD45- cells, but increased the percentages of αSMA-CD90+ 1	
(fibroblast phenotype) and αSMAlowCD90+ (myofibroblasts). B – Quantification of 2	
LAMP2 expression by αSMAhighCD90- cells (VSMCs), αSMA-CD90+ (fibroblast 3	
phenotype) and αSMAlowCD90+ (myofibroblasts) and flow chart showing the 4	
expression of LAMP2 by αSMAhighCD90- cells (VSMCs). *p<0.05 AngII (AD) vs AngII 5	
(no AD) and untreated Apoe-/- mice, Kruskal-Wallis test followed by Uncorrected 6	
Dunn's test. C – Representative dot plots showing the percentage of αSMAhighCD90- 7	
cells (VSMCs) expressing CD68 in untreated Apoe-/- mice (left panel) and AngII 8	
treated Apoe-/- mice without (middle panel) or with (right panel) aortic dissection (AD). 9	
D – Quantification of CD68 expression by aortic αSMAhighCD90- cells (VSMCs), 10	
αSMA-CD90+ (fibroblast phenotype) and αSMAlowCD90+ (myofibroblasts). *p<0.05 11	
AngII (AD) vs AngII (no AD) and untreated Apoe-/- mice, Kruskal-Wallis test followed 12	
by Uncorrected Dunn's test. E – Representative dot plots showing the percentage of 13	
αSMA-CD90+ (fibroblast phenotype) and αSMAlowCD90+ (myofibroblasts) expressing 14	
CD68 in dissected aortas. F – Representative dot plots showing the percentage of 15	
Ter-119 positive αSMAhighCD90- cells (VSMCs). G – Quantification of Ter-119 16	
positive αSMAhighCD90- cells (VSMCs), αSMA-CD90+ (fibroblast phenotype) and 17	
αSMAlowCD90+ (myofibroblasts). * p<0.05 AngII (AD) vs AngII (no AD) and untreated 18	
Apoe-/- mice, Kruskal-Wallis test followed by Uncorrected Dunn's test. H – 19	
Representative dot plots showing the percentage of Ter-119 positive αSMAnegCD90+ 20	
(fibroblasts) and αSMAintCD90+ (myofibroblasts) in aortas with aortic dissection (AD).  21	
 22	
Figure 3. VSMCs undergo clonal proliferation and phenotypic switching upon 23	
AngII treatment and aortic dissection.  24	
	 25	
A, B - Representative confocal images of abdominal aortic cross-sections from 1	
Myh11-CreERt2/Rosa26-Confetti animals treated with AngII and anti-TGFβ. Signals 2	
for confetti colors (blue = CFP, yellow = YFP, red = RFP, green = GFP), 3	
immunostaining for anti-αSMA (magenta) and DAPI (white) are shown as indicated. 4	
(A) αSMA+ cells observed in the false channel of Confetti animals that developed an 5	
aortic dissection express the genetic Confetti lineage label, demonstrating that they 6	
are derived from Myh11-expressing VSMCs. Notably, the non-random color 7	
distribution of VSMC-derived cells in the adventitia indicates clonal expansion of a 8	
small number of cells. (B) Monochromatic patches of VSMC-derived cells in the 9	
media express lower levels of αSMA compared to non-expanding medial VSMCs. C - 10	
Quantification of clonal expansion in the media, represented as the fraction of 11	
monochromatic patches with ≥5 cells/patch, in the aorta of Myh11-CreERt2/Rosa26-12	
Confetti/Apoe-/- mice treated with AngII alone or AngII + anti-TGFβ, compared to 13	
healthy controls (No AngII). Blocking TGFβ activity did not alter clonal VSMC 14	
expansion. 67-318 VSMC patches were analyzed per mouse. No AngII: n=4, AngII: 15	
n=14; AngII + anti-TGFβ: n=10. *p<0.05 for No AngII vs. AngII and No AngII vs.  16	
AngII + anti-TGFβ. Data were analyzed using Kruskal-Wallis test followed by 17	
Uncorrected Dunn's test. D - Quantification of EdU incorporation in VSMC-derived, 18	
Confetti-positive cells in Myh11-CreERt2/Rosa26-Confetti/Apoe-/- mice infused with 19	
AngII ± anti-TGFβ and injected with EdU from day 14 to day 21 of AngII infusion. 20	
AngII: n=13; AngII + anti-TGFβ: n=9. E, F - Representative confocal images of EdU 21	
staining in sections from AngII-treated Myh11-CreERt2/Rosa26-Confetti/Apoe-/- mice. 22	
Clonal expansion of VSMCs in the media (E) and adventitial outgrowth (F) is 23	
associated with DNA synthesis (proliferation) after AngII infusion. Arrow heads 24	
(colored according to Confetti color) indicate EdU+ VSMCs. A low magnification 25	
	 26	
image of panels F and G is available as Figure IV in the online-only Data 1	
Supplement. G - Representative images showing expression of HMOX1, CD68 and 2	
LAMP2 in sections of a dissected aorta from Myh11-CreERt2/Rosa26-Confetti/Apoe-/- 3	
mice infused with AngII. Images show adventitial regions containing VSMC-derived 4	
cells and yellow arrow heads indicate Confetti-positive VSMC-derived cells 5	
expressing HMOX1, CD68 or LAMP2. L: Lumen, M: Media, A: adventitia. 6	
 7	
Figure 4. ATG5 deletion in VSMCs (TalgnCre+/Atg5flox/flox mice) increases 8	
susceptibility to aortic rupture induced by AngII and anti-TGFβ infusion.  9	
A – Representative images of anti-αSMA and anti-ATG16L1 staining of abdominal 10	
aortic cross sections from untreated mice (healthy aorta, n=3) and mice infused with 11	
AngII and anti-TGFβ that developed a dissection (n=5). αSMA+ cells (in the media 12	
and in the adventitial outgrowth) express elevated levels of ATG16L1 compared to 13	
healthy controls and the staining shows a punctuate pattern, suggesting that 14	
autophagosomes are forming. B-F – TaglnCre- (n=14, black) and TaglnCre+ (n=17, 15	
white) Atg5flox/flox male littermate mice were infused with AngII + anti-TGFβ. B – 16	
Survival curves. *p<0.05 TaglnCre- vs TaglnCre+, Log-rank (Mantel-Cox) test. C – 17	
Representative images of thoraco-abdominal aorta. D – Severity of aortic dissections 18	
assessed macroscopically (I-normal appearance; II-thickening of the aortic wall; III- 19	
dissection; IV-fatal aortic rupture). *p<0.05 TaglnCre- vs TaglnCre+, Chi square test. E-F 20	
– Quantification (E) and representative pictures (F) of iron deposition (blue Perl’s 21	
staining) in the aortic wall (I-no iron deposition; II-mild iron deposition; III- substantial 22	
iron accumulation in some cells; IV-high accumulation of iron in numerous cells). 23	
*p<0.05 TaglnCre- vs TaglnCre+, Chi squared test. 24	
 25	
	 27	
Figure 5. Impaired autophagy in VSMCs impairs autophagosome formation and 1	
enhances cell death. 2	
A-D – Aortic cross section from TaglnCre- (n=14, black) and TaglnCre+ (n=17, white) 3	
Atg5flox/flox mice infused with AngII + anti-TGFβ for 28 days were analyzed by 4	
confocal microscopy. A – Representative images showing αSMA staining (top 5	
panels) and LC3 signal (lower panels). The quantification of autophagosome 6	
formation in VSMCs was done using a filter showing background in Cyan, low LC3 7	
staining appears in black and LC3 bright spots in white (Autophagosomes). 8	
***p<0.001 TaglnCre- vs TaglnCre+, Mann-Whitney test. B – Representative images 9	
showing αSMA (top) and p62 staining (lower panel). Quantification of p62 signal in 10	
αSMA-positive VSMCs is shown to the right. ***p<0.001 TaglnCre- vs TaglnCre+, Mann-11	
Whitney test. C – Representative images showing LAMP2 and αSMA staining and 12	
quantification of lysosome accumulation in VSMCs. **p<0.01 TaglnCre- vs TaglnCre+, 13	
Mann-Whitney test. D – Representative images showing αSMA and active 14	
CASPASE-3 staining. Quantification of the number of active CASPASE-3-positive 15	
apoptotic cells in the media is shown on the right. *p<0.05 TaglnCre- vs TaglnCre+, 16	
Mann-Whitney test. E-F – Primary VSMCs were derived from the aorta of TaglnCre- 17	
and TaglnCre+ Atg5flox/flox mice and cultured for 4-7 passages prior to analysis. Mean ± 18	
SEM of technical quadruplicates are shown. E – Serum starved VSMCs were 19	
stimulated with serum and cell density analyzed by MTT. *p<0.05, ***p<0.001 20	
TaglnCre- vs TaglnCre+ at each time point, 2-way ANOVA followed by uncorrected 21	
Fisher’s test. F – BrdU incorporation by serum starved VSMCs and cells 22	
supplemented with FBS for 48 hours. *p<0.05 TaglnCre- vs TaglnCre+ with 10% FBS, 23	
Mann-Whitney test. G – VSMCs were incubated with increasing doses of 24	
Thapsigargin for 16 hours. Cell density was analyzed using MTT assay and 25	
	 28	
normalized to untreated TaglnCre- cells. **p<0.01, ***p<0.001 TaglnCre- vs TaglnCre+ at 1	
each time point, 2-way ANOVA followed by uncorrected Fisher’s test. 2	
 3	
Figure 6. ATG5 deficiency in VSMCs promotes inflammation via the ER-stress 4	
sensor IRE1α. 5	
A – Representative images and quantification of IRE1α immunofluorescence signals 6	
in αSMA+ cells on aortic cross-sections from TaglnCre- (n=14, black) and TaglnCre+ 7	
(n=17, white) Atg5flox/flox mice infused with AngII and anti-TGFβ for 28 days. **p<0.01 8	
TaglnCre- vs TaglnCre+, Mann-Whitney test. B – Representative images of IRE1α 9	
immunostaining of primary VSMCs derived from the aorta of TaglnCre- and TaglnCre+ 10	
Atg5flox/flox mice cultured in vitro. C – IL-6 secretion by primary VSMCs derived from 11	
the aorta of TaglnCre- and TaglnCre+ Atg5flox/flox mice stimulated for 16 hours with IL1β 12	
(100 pg/ml) in the presence or absence of the IRE1α kinase inhibitor (Apy29, 20µM) 13	
in vitro. Mean ± SEM of technical quadruplicates are shown. *p<0.05, ***p<0.001 14	
TaglnCre- vs TaglnCre+, 2-way ANOVA followed by uncorrected Fisher’s test. D – 15	
Representative images and quantification of Ly6G immunostaining on aortic cross-16	
sections from TaglnCre- (n=14) and TaglnCre+ (n=17) Atg5flox/flox mice infused with AngII 17	
+ anti-TGFβ for 28 days. *p<0.05 TaglnCre- vs TaglnCre+, Mann-Whitney test. 18	
 19	
Figure 7. Human aortic dissections are associated with impaired autophagy 20	
and ER-stress response in VSMCs. 21	
A-D – Human thoracic aortic samples from non-dissected (n=4-5) and dissected 22	
(n=5) aortas were immunostained and analyzed by confocal microscopy. A –23	
Representative images showing that αSMA+ and TAGLN+ cells are detected outside 24	
the media (dotted line depicts the external elastic laminae) in the adventitial layer of 25	
	 29	
dissected thoracic aorta (4 out of 5 samples) but not in non-dissected samples (0 out 1	
of 5 samples). B-D – Representative images and quantification of the expression of 2	
LC3 (B), SQSTM1/p62 (C) and GRP78/Bip (D) in αSMA+ cells in the media of non-3	
dissected (n=4-5, white) and dissected aortic samples (n=5, black). *p<0.05 non-4	




Figure 1. aSMA+ cells accumulate outside of the media and express phagocytic makers after aortic dissection. 
A-C – Representative images of anti-aSMA staining on cross sections of abdominal aortas from mice treated with AngII and anti-
TGFb for 10 days showing aSMA+ cell outgrowths from the medial layer (A, right panel), as compared to sections from control mice 
(A, left panel). On consecutive sections, Perl’s (B) and anti-HMOX1 (C) staining show that aSMA+ cells in an iron rich environment 
(Perl’s
+
) express the heme catabolic enzyme (HMOX1). D-F – Representative images of cryosections co-stained for aSMA and 
CD68 (D) or LAMP2 (E) showing that CD68 and LAMP2 colocalize with aSMA+ cells in the adventitial layers of aortic dissection. 
Hoechst (blue) represents nuclear staining. Images are representative of immunostainings done on 5 mice with aortic dissection. 
 
 
Figure 2. Vascular smooth muscle cells, fibroblasts and myofibroblasts express 
phagocytic markers after aortic dissection (AD). 
Flow cytometric analysis of stromal cells (CD45-) in the aorta of 5-month-old male Apoe-/- mice 
infused with AngII for 21 days (n=13). Littermate control Apoe-/- mice were left untreated (top 
panel, n=4).  A – Left panel: Representative images of aortic samples from untreated or AngII 
infused Apoe-/- mice that either did not (no AD) or did develop an aortic dissection (AD). 
Enzymatically digested aortas were analysed by flow cytometry. Middle/right panel: 
Representative dot plots showing the gating strategy used to analyze aSMAhighCD90- cells 
(VSMCs), aSMA-CD90+ (fibroblast phenotype) and aSMAlowCD90+ (myofibroblasts). Aortic 
dissection induced by AngII (lower panel, n=4 mice) dramatically reduced the percentage of 
aSMAhighCD90- cells (VSMCs) within CD45- cells, but increased the percentages of aSMA-
CD90+ (fibroblast phenotype) and aSMAlowCD90+ (myofibroblasts). B – Quantification of LAMP2 
expression by aSMAhighCD90- cells (VSMCs), aSMA-CD90+ (fibroblast phenotype) and 
aSMAlowCD90+ (myofibroblasts) and flow chart showing the expression of LAMP2 by 
aSMAhighCD90- cells (VSMCs). *p<0.05 AngII (AD) vs AngII (no AD) and untreated Apoe-/- mice, 
Kruskal-Wallis test followed by Uncorrected Dunn's test. C – Representative dot plots showing 
the percentage of aSMAhighCD90- cells (VSMCs) expressing CD68 in untreated Apoe-/- mice 
(left panel) and AngII treated Apoe-/- mice without (middle panel) or with (right panel) aortic 
dissection (AD). D – Quantification of CD68 expression by aortic aSMAhighCD90- cells (VSMCs), 
aSMA-CD90+ (fibroblast phenotype) and aSMAlowCD90+ (myofibroblasts). *p<0.05 AngII (AD) vs 
AngII (no AD) and untreated Apoe-/- mice, Kruskal-Wallis test followed by Uncorrected Dunn's 
test. E – Representative dot plots showing the percentage of aSMA-CD90+ (fibroblast 
phenotype) and aSMAlowCD90+ (myofibroblasts) expressing CD68 in dissected aortas. F – 
Representative dot plots showing the percentage of Ter-119 positive aSMAhighCD90- cells 
(VSMCs). G – Quantification of Ter-119 positive aSMAhighCD90- cells (VSMCs), aSMA-CD90+ 
(fibroblast phenotype) and aSMAlowCD90+ (myofibroblasts). * p<0.05 AngII (AD) vs AngII (no 
AD) and untreated Apoe-/- mice, Kruskal-Wallis test followed by Uncorrected Dunn's test. H – 
Representative dot plots showing the percentage of Ter-119 positive aSMAnegCD90+ 
(fibroblasts) and aSMAintCD90+ (myofibroblasts) in aortas with aortic dissection (AD). 
 
Figure 3 
Figure 3. VSMCs undergo clonal proliferation and phenotypic switching upon AngII treatment and aortic dissection.  
A, B - Representative confocal images of abdominal aortic cross-sections from Myh11-CreERt2/Rosa26-Confetti animals treated 
with AngII and anti-TGFb. Signals for confetti colors (blue = CFP, yellow = YFP, red = RFP, green = GFP), immunostaining for anti-
aSMA (magenta) and DAPI (white) are shown as indicated. (A) aSMA+ cells observed in the false channel of Confetti animals that 
developed an aortic dissection express the genetic Confetti lineage label, demonstrating that they are derived from Myh11-
expressing VSMCs. Notably, the non-random color distribution of VSMC-derived cells in the adventitia indicates clonal expansion of 
a small number of cells. (B) Monochromatic patches of VSMC-derived cells in the media express lower levels of aSMA compared to 
non-expanding medial VSMCs.  
C - Quantification of clonal expansion in the media, represented as the fraction of monochromatic patches with ≥5 cells/patch, in the 
aorta of Myh11-CreERt2/Rosa26-Confetti/Apoe-/- mice treated with AngII alone or AngII + anti-TGFb, compared to healthy controls 
(No angII). Blocking TGFb activity did not alter clonal VSMC expansion. 67-318 VSMC patches were analyzed per mouse. No angII: 
n=4, AngII: n=14; AngII + anti-TGFb: n=10. *p<0.05 for No angII vs. AngII and No angII vs.  AngII + anti-TGFb. Data were analysed 
using Kruskal-Wallis test followed by Uncorrected Dunn's test. 
D - Quantification of EdU incorporation in VSMC-derived, Confetti-positive cells in Myh11-CreERt2/Rosa26-Confetti/Apoe-/- mice 
infused with AngII ± anti-TGFb and injected with EdU from day 14 to day 21 of AngII infusion. AngII: n=13; AngII + anti-TGFb: n=9. 
E, F - Representative confocal images of EdU staining in sections from AngII-treated Myh11-CreERt2/Rosa26-Confetti/Apoe-/- mice. 
Clonal expansion of VSMCs in the media (E) and adventitial outgrowth (F) is associated with DNA synthesis (proliferation) after 
AngII infusion. Arrow heads (colored according to Confetti color) indicate EdU+ VSMCs. A low magnification image of panels F and 
G is available as Figure IV in the online-only Data Supplement. 
G - Representative images showing expression of HMOX1, CD68 and LAMP2 in sections of a dissected aorta from Myh11-
CreERt2/Rosa26-Confetti/Apoe-/- mice infused with AngII. Images show adventitial regions containing VSMC-derived cells and 
yellow arrow heads indicate Confetti-positive VSMC-derived cells expressing HMOX1, CD68 or LAMP2. 
L: Lumen, M: Media, A: adventitia.
 
Figure 4. ATG5 deletion in VSMCs (TalgnCre+/Atg5flox/flox mice) increases 
susceptibility to aortic rupture induced by AngII and anti-TGFb infusion.  
A – Representative images of anti-aSMA and anti-ATG16L1 staining of abdominal 
aortic cross sections from untreated mice (healthy aorta, n=3) and mice infused with 
AngII and anti-TGFb that developed a dissection (n=5). aSMA+ cells (in the media 
and in the adventitial outgrowth) express elevated levels of ATG16L1 compared to 
healthy controls and the staining shows a punctuate pattern, suggesting that 
autophagosomes are forming. 
B-F – TaglnCre- (n=14, black) and TaglnCre+ (n=17, white) Atg5flox/flox male littermate 
mice were infused with AngII + anti-TGFb. B – Survival curves. *p<0.05 TaglnCre- vs 
TaglnCre+, Log-rank (Mantel-Cox) test. C – Representative images of thoraco-
abdominal aorta. D – Severity of aortic dissections assessed macroscopically (I-
normal appearance; II-thickening of the aortic wall; III- dissection; IV-fatal aortic 
rupture). *p<0.05 TaglnCre- vs TaglnCre+, Chi square test. E-F – Quantification (E) and 
representative pictures (F) of iron deposition (blue Perl’s staining) in the aortic wall (I-
no iron deposition; II-mild iron deposition; III- substantial iron accumulation in some 
cells; IV-high accumulation of iron in numerous cells). *p<0.05 TaglnCre- vs TaglnCre+, 
Chi squared test. 
 
Figure 5. Impaired autophagy in VSMCs impairs autophagosome formation and 
enhances cell death. 
A-D – Aortic cross section from TaglnCre- (n=14, black) and TaglnCre+ (n=17, white) Atg5flox/flox 
mice infused with AngII + anti-TGFb for 28 days were analyzed by confocal microscopy. A – 
Representative images showing aSMA staining (top panels) and LC3 signal (lower panels). 
The quantification of autophagosome formation in VSMCs was done using a filter showing 
background in Cyan, low LC3 staining appears in black and LC3 bright spots in white 
(Autophagosomes). ***p<0.001 TaglnCre- vs TaglnCre+, Mann-Whitney test. B – Representative 
images showing aSMA (top) and p62 staining (lower panel). Quantification of p62 signal in 
aSMA-positive VSMCs is shown to the right. ***p<0.001 TaglnCre- vs TaglnCre+, Mann-Whitney 
test. C – Representative images showing LAMP2 and aSMA staining and quantification of 
lysosome accumulation in VSMCs. **p<0.01 TaglnCre- vs TaglnCre+, Mann-Whitney test. D – 
Representative images showing aSMA and active CASPASE-3 staining. Quantification of the 
number of active CASPASE-3-positive apoptotic cells in the media is shown on the right. 
*p<0.05 TaglnCre- vs TaglnCre+, Mann-Whitney test. E-F – Primary VSMCs were derived from 
the aorta of TaglnCre- and TaglnCre+ Atg5flox/flox mice and cultured for 4-7 passages prior to 
analysis. Mean ± SEM of technical quadruplicates are shown. E – Serum starved VSMCs 
were stimulated with serum and cell density analyzed by MTT. *p<0.05, ***p<0.001 TaglnCre- 
vs TaglnCre+ at each time point, 2-way ANOVA followed by uncorrected Fisher’s test. F – 
BrdU incorporation by serum starved VSMCs and cells supplemented with FBS for 48 hours. 
*p<0.05 TaglnCre- vs TaglnCre+ with 10% FBS, Mann-Whitney test. 
G – VSMCs were incubated with increasing doses of Thapsigargin for 16 hours. Cell density 
was analyzed using MTT assay and normalized to untreated TaglnCre- cells. **p<0.01, 
***p<0.001 TaglnCre- vs TaglnCre+ at each time point, 2-way ANOVA followed by uncorrected 
Fisher’s test. 
 
Figure 6. ATG5 deficiency in VSMCs promotes inflammation via the ER-stress sensor IRE1a. 
A – Representative images and quantification of IRE1a immunofluorescence signals in aSMA+ cells on aortic cross-sections from 
TaglnCre- (n=14, black) and TaglnCre+ (n=17, white) Atg5flox/flox mice infused with AngII and anti-TGFb for 28 days. **p<0.01 TaglnCre- 
vs TaglnCre+, Mann-Whitney test. B – Representative images of IRE1a immunostaining of primary VSMCs derived from the aorta of 
TaglnCre- and TaglnCre+ Atg5flox/flox mice cultured in vitro. C – IL-6 secretion by primary VSMCs derived from the aorta of TaglnCre- and 
TaglnCre+ Atg5flox/flox mice stimulated for 16 hours with IL1b (100 pg/ml) in the presence or absence of the IRE1a kinase inhibitor 
(Apy29, 20µM) in vitro. Mean ± SEM of technical quadruplicates are shown. *p<0.05, ***p<0.001 TaglnCre- vs TaglnCre+, 2-way 
ANOVA followed by uncorrected Fisher’s test. D – Representative images and quantification of Ly6G immunostaining on aortic 
cross-sections from TaglnCre- (n=14) and TaglnCre+ (n=17) Atg5flox/flox mice infused with AngII + anti-TGFb for 28 days. *p<0.05 
TaglnCre- vs TaglnCre+, Mann-Whitney test. 
 
 
Figure 7. Human aortic dissections are associated with impaired autophagy and ER-stress response in VSMCs. 
A-D – Human thoracic aortic samples from non-dissected (n=4-5) and dissected (n=5) aortas were immunostained and analyzed by confocal 
microscopy. A –Representative images showing that aSMA+ and TAGLN+ cells are detected outside the media (dotted line depicts the external 
elastic laminae) in the adventitial layer of dissected thoracic aorta (4 out of 5 samples) but not in non-dissected samples (0 out of 5 samples). B-
D – Representative images and quantification of the expression of LC3 (B), SQSTM1/p62 (C) and GRP78/Bip (D) in aSMA+ cells in the media of 
non-dissected (n=4-5, white) and dissected aortic samples (n=5, black). *p<0.05 non-dissected vs dissected, Mann-Whitney test.  
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SUPPLEMENT MATERIAL 
Vascular Smooth Muscle Cell Plasticity and Autophagy in 
Dissecting Aortic Aneurysms 




All the experiments were approved by the local ethics committee and done under 
Home Office, UK licenses PA4BDF775 and 70/7555. 
In order to lineage label VSMCs, Myh11-CreERt2/ROSA26-Confetti and Myh11-
CreERt2/ROSA26-Confetti/Apoe-/- male mice (previously described in Chappell et 
al.1), received 10 injections of tamoxifen diluted in corn oil (1mg/mouse/injection, i.p.) 
over 2 weeks. Mice were left for a week to clear excess tamoxifen, before further 
treatment. 
Myh11-CreERt2/ROSA26-Confetti mice were infused with AngII (1µg/min/Kg, Sigma) 
using osmotic pumps and anti-TGFβ (10mg/Kg, clone 1.D.11, BioXCell) was injected 
i.p. (3 times/week) and tissues were harvested at different time points between day 7 
and day 28. Out of 22 animals treated with AngII, 4 died within one week and were 
excluded from the analysis. Of the remaining, 6 animals showed macroscopic 
evidence of aortic dissection and were analyzed for VSMC phenotype by confocal 
microscopy. Additionally, one of the animals which appeared to have a normal aorta 
was also analyzed by confocal microscopy. 
Myh11-CreERt2/ROSA26-Confetti/Apoe-/- mice were infused with AngII (1µg/min/Kg) 
using osmotic pumps, and inhibition of TGFβ activity (10mg/Kg, clone 1.D.11, 3 
times/week, i.p.) started 14 days after the beginning of AngII infusion. Mice were 
injected daily with EdU (1mg/mouse) i.p. for a week, starting on day 14. A total of 25 
animals were treated with AngII in three independent experiments and 10 of these 
received anti-TGFβ injections (5 animals per experiment in two experiments). All 
animals were processed for analysis by confocal microscopy.  
For flow cytometry experiments, 5-month-old male Apoe-/- mice were subjected to 
AngII infusion (n=13), or left untreated (n=4), for 21 days later. 2 out of the 6 mice 
infused with AngII developed an aortic dissection. Aortic tissues were harvested, 
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dispersed enzymatically to a single cell suspension as described 2 and analyzed by 
flow cytometry. 
TaglnCre+ mice (Jax n°004746) and Atg5flox/flox mice (kindly provided by Noburu 
Mizushima, University of Tokyo) were crossed and male littermates TaglnCre+ (n=14) 
and TaglnCre- (n=17) on Atg5flox/flox background were infused with AngII (1µg/min/Kg, 
Sigma) and anti-TGFβ (10mg/Kg, clone 1.D.11, 3 times/week, i.p.). Data are from 2 
independent experiments. Blood pressure measurements were obtained by the tail 
cuff method. Necropsies were performed to confirm vascular rupture of animals that 
died prior to day 28, and the aortas were harvested and fixed in 4% PFA. Surviving 
mice were culled at day 28, perfused with cold PBS and aortic samples were fixed in 
PFA 4% overnight at 4°C, and kept in PBS at 4°C for further investigation. 
Assessment of aortic dissection stage (I-normal appearance; II-thickening of the 
aortic wall; III-dissection; IV-fatal aortic rupture) was done blinded to genotype. 
	
Tissue processing and quantification of medial patches in lineage-traced 
animals. Aortas were fixed in 4% PFA overnight at 4oC, embedded in OCT and 
cryosectioned (12 µm) as described in Chappell et al. 1. Sections were stained for 
antigens of interest, EdU incorporation and the nuclei were counter stained with DAPI 
as described 1 using the primary antibodies listed below, except for αSMA stainings 
that were done using a biotinylated primary antibody (Abcam clone 1A4) and Alexa 
Fluor® 647 Streptavidin (Biolegend). Secondary antibodies were all Alexa Fluor® 
647 conjugated to avoid spectral overlap with the Confetti reporter proteins. Sections 
were mounted in RapiClear and imaged using an Sp8 Leica confocal microscope as 
previously described 1, with a 2.5 µm distance between scans. The number of EdU+ 
cells per section was quantified in Imaris (Bitplane, Oxford Instruments) to ensure 
that EdU+ nuclei were scored correctly for Confetti signal. Quantification of Confetti 
patch size within the media was performed in imaged sections within the Imaris 
section viewer, with Z-stack thickness of 3.5 µm. Within each "ring" of the artery 
(delineated by the elastic lamella) each cell was scored for its Confetti color (or 
absence of) cell by cell and the frequency of occurrence of contiguous runs of one 
Confetti color calculated for each patch size.  
 3 
Immunofluorescence. Aortic samples were cleaned of surrounding tissues, 
embedded in OCT and cryosectioned. Immunofluorescent stainings were performed 
as described in Clement et al. 2. Sections were stained with mouse anti-
mouse/human αSMA-Cy3™ (Sigma, clone: 1A4), rabbit anti-mouse HMOX1 (Abcam, 
clone: EP1391Y), rat anti-mouse CD68 (Biorad clone: FA-11), rat anti-mouse LAMP2 
(SantaCruz biotech, clone: M3/84), rabbit anti-mouse ATG16L1 (Cell Signaling 
Technology®, clone: D6D5), rabbit anti-mouse ATG5 (LifeSpan BioSciences LS-
B1843), rabbit IgG control (Abcam ab27478), rabbit anti-mouse/human LC3 (Cell 
Signaling Technology®, clone: D11), rabbit ant-mouse/human Sqstm1/p62 (Abcam, 
ab207305), rabbit anti-mouse active CASPASE3 (Cell Signaling Technology®, clone: 
D3D9), rabbit anti-mouse/human IRE1α (Cell Signaling Technology®, clone: 14C10), 
rat anti-mouse Ly6G (eBiosciences, clone: RB6-8C5), rabbit anti-human GRP78/Bip 
(Cell Signaling Technology®, clone: C50B12) and rabbit anti-human TAGLN (Abcam, 
ab14106). Primary antibodies were revealed using donkey anti-rabbit Alexa Fluor® 
555 (Invitrogen), goat anti-rat Alexa Fluor® 488 (Invitrogen) or goat anti-rabbit Alexa 
Fluor® 647 (Invitrogen, and Abcam ab150079). 
 
EdU incorporation was detected using the Click-iT® Plus EdU Alexa Fluor® 647 
Imaging kit (Life Tehcnologies) according to the manufacturer’s instructions. 
 
Sections from human aortic samples were obtained by P. Bruneval, Paris, France. At 
the time of collection, those samples were considered waste necropsy or post-
surgery material and did not require specific ethics approval. Human samples from 
non-dissected thoracic aortas (n=5) were obtained from men (age 44-68 years old) 
suffering from traumatic injury of the ascending aorta (n=1), valvular surgery (n=1) or 
from transplantation-recused hearts (n=3). Tissues from dissected thoracic aortas 
(n=5; 4 ascending, 1 descending) were obtained from men (age 53-75 years old) 
suffering from chronic (n=3) or acute dissection (n=2) associated with degenerative 
disease (no bicuspid valves). Deparaffinization and staining were performed as 
described in Clement et al. 2. Imaging of epifluorescent and brightfield stainings was 
performed using a Leica DM6000B microscope, and images were analyzed using 
Adobe Photoshop CS5 and ImageJ (NIH). Immunofluorescent imaging by confocal 




Perl’s staining and assessment of iron accumulation. Sections were stained 
according to the manufacturer’s instructions (Sigma, HT20-1KT). Iron staining was 
graded as follow: I-no iron deposition; II-mild iron deposition; III-high iron 
accumulation in some cells; IV-high accumulation of iron in numerous cells. 
 
Flow cytometry. Aortic samples were digested and cell suspensions were stained 
following the protocol described in Clement et al. 2. Extracellular antigens were 
stained using rat anti-mouse CD45-eVolve605TM (eBiosciences, clone: 30F11) or 
anti-CD45-APC, (Biolegend, clone: 30F11), rat anti-mouse CD31-PE-Cy7 
(eBiosciences, clone: 390), rat anti-mouse CD90.2-BV786TM (BD Biosciences, clone: 
53-2.1) and Zombie Yellow™ Fixable Viability Kit (Biolegend). Cells were then 
fixed/permeabilized using a transcription factor staining buffer set (eBioscience™ 
Foxp3) according to the manufacturer’s instructions, and intracellular antigens were 
stained using mouse anti-mouse αSMA-Cy3™ (Sigma, clone: 1A4), rat anti-mouse 
CD68-BV605TM (Biolegend, clone: FA-11), rat anti-mouse LAMP2-FITC 
(eBiosciences, clone: eBioABL-93), anti-Ter-119-FITC (eBiosciences, clone: Ter-
119). Flow cytometric acquisition of the cell suspension was performed on a LSR II 
Fortessa (BD biosciences) equipped with 4 lasers (405, 488, 561 and 640 nm). 
Analysis was done using BD FACSDiva Software 6.0 and figure-displayed dot plots 
and histograms were obtained using FlowJo software (TreeStar). 
 
Cell culture. VSMC primary cultures were obtained using aortas from female 
Atg5flox/flox TaglnCre- and TaglnCre+ littermates. Briefly, aortas were cleaned from 
surrounding tissues, minced into small pieces, and subjected to enzymatic digestion 
(RPMI 1640, collagenase D [0.2 mg/ml, Roche], dispase [1 U/ml, StemcellTM 
Technologies] and elastase [1 mg/ml, Worthington biochemical Corporation]) for 45 
min at 37°C. Cells were allowed to grow in complete medium (RPMI 1640 containing 
L-glutamine + 10 % [vol/vol] heat-inactivated FBS, 100 IU/ml penicillin, 100 µg/ml 
streptomycin) until passage 4 and were then aliquoted and frozen in liquid nitrogen. 
Serum induced proliferation of VSMC was done after overnight serum starvation 
(0.5% serum) and complete medium was added onto the cells. Cell density was 
evaluated using MTT assays (CGD1-1KT, Sigma). For DNA synthesis analysis, cells 
were incubated with in the same conditions, and the medium (0.5% or 10% FBS) was 
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supplemented with BrdU (1mM). Cells were harvested 48 hours after FBS 
supplementation and BrdU incorporation was analyzed by flow cytometry according 
the manufacturer’s instruction (BD Biosciences, Kit BrdU, cat number: 559619). IL-6 
production after IL-1β stimulation was performed on cells plated at 1x105 cells/well, 
left overnight to adhere in complete medium. Cells were washed and stimulated with 
fresh medium containing either 0.1% DMSO (vehicle), vehicle + IL-1β (100 pg/ml, 
Biolegend), or IL-1β + Apy29 (20 µM, Tocris). After 24 hours, supernatants were 
collected and IL-6 secretion was analyzed using CBA Mouse IL-6 Flex Set (BD 
Biosciences). Death induced by thapsigargin (Sigma) was measured on VSMCs 
plated at 1x105 cells/well, left overnight to adhere in complete medium. Medium was 
replaced with fresh medium containing increasing concentration of thapsigargin (0-
1µM). After 24 hours, cell density was assessed using MTT assay. Tests were 
performed in quadruplicate. 
 
Quantitative real time polymerase chain reaction. RNA was harvested from 
VSMCs 24 hours after plating (1x105 cells/well, in quadruplicate), extracted using 
RNeasy minikit (Qiagen) following manufacturer’s instructions. 150 ng of RNA was 
reverse-transcribed (QuantiTect Rev. Transcription Kit; Qiagen) and 5 µl of cDNA 
(diluted 20-fold) was used to analyze the expression of Atg5 using SYBR Green 
qPCR mix (Eurogentec) on a Roche lightcycler with the following primers: Atg5 for 5’-
>3’: CCCCTGAAATGGCATTATCCAA; Atg5 rev 5’->3’: 
AAAGTGAGCCTCAACCGCAT. 
Il6 for 5’->3’: CCAGAGATACAAAGAAATGATGG; Il6 rev 5’->3’: 
ACTCCAGAAGACCAGAGGAAAT. Cxcl1 for 5’->3’: CAGACCATGGCTGGGATTCA; 
Cxcl1 rev 5’->3’: AGTGTGGCTATGACTTCGGTTT. Ccl2 for 5’->3’: 
GTTAACGCCCCACTCACCT; Ccl2 rev 5’->3’: TTCTTTGGGACACCTGCTG. House 
keeping gene: 36b4 for 5’->3’: TCTCCAGAGGCACCATTGAAA; 36b4 rev 5’->3’ 
CTCGCTGGCTCCCACCTT. 
 
Statistical analysis. Values are shown as average ± SEM. Statistical analysis was 
performed using Prism GraphPad and differences between groups were evaluated 
using Mann-Whitney test (2 groups), Kruskal-Wallis test followed by uncorrected 
Dunn’s test (> 2 groups), 2-way ANOVA (cell proliferation/survival) or Chi-squared 
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test (Distribution between 2 groups), as indicated in the figure legends. Results were 








Figure I: Monochromatic patches in the media of Myh11-CreERt2/Rosa26-
Confetti mice after AngII + anti-TGFβ infusion. 
Representative pictures of monochromatic patches of VSMCs in the media of Myh11-
CreERt2/Rosa26-Confetti mice after AngII + anti-TGFβ infusion analyzed by confocal 






Figure II: Reduced expression of αSMA by clonally expanded medial VSMCs. 
A – Representative images of αSMA staining of aortic cross sections from Myh11-
CreERt2/Rosa26-Confetti mice after AngII + anti-TGFβ infusion. Monochromatic 
patches express lower levels of αSMA, compared to regions displaying the mosaic 
color pattern also observed in healthy vessels. Red arrow heads point to αSMA+ 
Confetti-positive cells in a red patch of clonally expanded VSMCs. 
B – Quantification of αSMA mean fluorescence intensity (MFI) in Confetti+ cells from 
areas of the media, without clonal expansion (white circles) versus medial 
monochromatic patches (black circles, n=3) or adventitial outgrowths (black squares, 
n=3). For each region, 15 cells were analyzed per animal, and the MFI of αSMA from 
the expanded cells was normalized to the MFI of non-expanded cells from the same 
section (white circles). A total of 6 animals were used for quantification. *p<0.05 in 
media without clonal expansion vs other conditions. Kruskal-Wallis test followed by 






Figure III: Blocking TGFβ activity does not impair VSMCs outgrowth after aortic 
dissection. 
Representative images showing clonally expanded VSMCs in the adventitia of a 
Myh11-CreERt2/Rosa26-Confetti/Apoe-/- animal that developed dissection after 28 
days of AngII infusion and inhibition of TGFβ activity at day 14. The external elastic 





Figure IV: Representative image at low magnification of Figure 3F. 






Figure V. Expression of autophagy related genes in phenotypically switched 
VSMCs. 
A-C – Representative images of ATG16L1 (A) and ATG5 (B, C) staining (magenta) of 
aortic cross sections from AngII-treated, VSMC lineage labelled (Myh11-
CreERt2/Rosa26-Confetti) mice with aortic dissection (A, B) and TaglnCre-, Atg5flox/flox 
and TaglnCre+, Atg5flox/flox mice (C). 
D – Analysis of Atg5 and Atg16l1 expression by RT-Q-PCR in ex vivo and primary 
VSMCs cultured at passage 4. Mean ± SEM of biological triplicates, normalized to 




Figure VI. Expression of Atg5 and blood pressure measurements in TaglnCre- 
and TaglnCre+ Atg5flox/flox mice. 
A – Analysis of Atg5 expression by RT-Q-PCR of primary VSMCs derived from the 
aortas of TaglnCre- and TaglnCre+ Atg5flox/flox mice. *p<0.05 TaglnCre- vs TaglnCre+, 
Mann-Whitney test. Data were obtained using technical quadruplicates and are 
representative of two independent experiments. 
B – Systolic blood pressure (mmHg) from TaglnCre- (black, n=14 at the beginning of 
the experiment) and TaglnCre+ (white, n=17 at the beginning of the experiment) 






Figure VII. Atg5 deficiency in SMCs promotes a pro-inflammatory phenotype 
via IRE1α. 
A- Analysis of Il6, Ccl2 and Cxcl1 expression by RT-Q-PCR of primary VSMCs 
derived from the aortas of TaglnCre- + Atg5flox/flox and TaglnCre+ Atg5flox/flox mice 
stimulated for 16 hours with IL1β (1 µg/ml) in the presence or absence of the IRE1α 
kinase inhibitor (Apy29, 20µM) in vitro. Mean ± SEM of technical quadruplicates are 
shown. *p<0.05, ***p<0.001 TaglnCre- vs TaglnCre+, 2-way ANOVA followed by 
uncorrected Fisher’s test. 
B- Analysis of circulating cytokines (IL-6, IL-1b, IL-2, IFNg, KC/GRO, TNFa, IL-5, IL-
10) in the plasma of surviving TaglnCre-  Atg5flox/flox (n= 11) and TaglnCre+ Atg5flox/flox 






Figure VIII. αSMA expression in human thoracic aorta. 
Representative images of αSMA staining on human thoracic aorta without dissection 
(n=5) or with dissection (n=5) showing αSMA+ cells in the adventitia of dissected 





Figure IX. CD90-αSMA+ Human SMCs accumulate to the adventitia after aortic 
dissection. 
Representative examples of human thoracic aorta without dissections (2 examples 
are shown, 4 were analyzed) and with dissections (2 examples are shown, 5 were 
analyzed). Most of the αSMA+ cells outside of the media (limit shown by the dashed 
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